Search research articles
Contact Us
Filters
Showing results (11-20 of 17) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 17 results.
Nature Chemical Biology
|
October 25, 2016
Structural and conformational determinants of macrocycle cell permeability
Björn Over, Pär Matsson, Christian Tyrchan, et al.
ACS Infectious Diseases
|
February 21, 2017
Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile
Jeremy R Duvall, Leanne Bedard, Adel M Naylor-Olsen, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Diversity-oriented synthesis yields a new drug lead for treatment of chagas disease
Sivaraman Dandapani, Andrew R Germain, Ivan Jewett, et al.
ACS Chemical Biology
|
October 17, 2024
Novel Corrector for Variants of SLC6A8: A Therapeutic Opportunity for Creatine Transporter Deficiency
Lara N Gechijian, Giovanni Muncipinto, T Justin Rettenmaier, et al.
Journal of Medicinal Chemistry
|
September 12, 2014
Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agents
Eamon Comer, Jennifer A Beaudoin, Nobutaka Kato, et al.
JCI Insight
|
November 8, 2024
SLC6A19 inhibition facilitates urinary neutral amino acid excretion and lowers plasma phenylalanine
Heike J Wobst, Andreu Viader, Giovanni Muncipinto, et al.
The Journal of Organic Chemistry
|
August 3, 2012
Synthesis and profiling of a diverse collection of azetidine-based scaffolds for the development of CNS-focused lead-like libraries
Jason T Lowe, Maurice D Lee, Lakshmi B Akella, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 17) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 17 results.
Nature Chemical Biology
|
October 25, 2016
Structural and conformational determinants of macrocycle cell permeability
Björn Over, Pär Matsson, Christian Tyrchan, et al.
ACS Infectious Diseases
|
February 21, 2017
Identification of Highly Specific Diversity-Oriented Synthesis-Derived Inhibitors of Clostridium difficile
Jeremy R Duvall, Leanne Bedard, Adel M Naylor-Olsen, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Diversity-oriented synthesis yields a new drug lead for treatment of chagas disease
Sivaraman Dandapani, Andrew R Germain, Ivan Jewett, et al.
ACS Chemical Biology
|
October 17, 2024
Novel Corrector for Variants of SLC6A8: A Therapeutic Opportunity for Creatine Transporter Deficiency
Lara N Gechijian, Giovanni Muncipinto, T Justin Rettenmaier, et al.
Journal of Medicinal Chemistry
|
September 12, 2014
Diversity-oriented synthesis-facilitated medicinal chemistry: toward the development of novel antimalarial agents
Eamon Comer, Jennifer A Beaudoin, Nobutaka Kato, et al.
JCI Insight
|
November 8, 2024
SLC6A19 inhibition facilitates urinary neutral amino acid excretion and lowers plasma phenylalanine
Heike J Wobst, Andreu Viader, Giovanni Muncipinto, et al.
The Journal of Organic Chemistry
|
August 3, 2012
Synthesis and profiling of a diverse collection of azetidine-based scaffolds for the development of CNS-focused lead-like libraries
Jason T Lowe, Maurice D Lee, Lakshmi B Akella, et al.
Page
of 2